Sunday, February 5, 2023
  • Hype
  • Murai
  • Lipstiq
  • Diva
  • Varnam
  • Moviedash
  • Autofreaks
Lowyat.NET
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Hardware
      • Compu-zone
      • Viewnet
      • Thundermatch
      • Sri Computers
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables
No Result
View All Result
Lowyat.NET
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Hardware
      • Compu-zone
      • Viewnet
      • Thundermatch
      • Sri Computers
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables
No Result
View All Result
Lowyat.NET
No Result
View All Result
Home Coronavirus

Malaysia Gives Conditional Approval For Pfizer’s Paxlovid COVID-19 Drug (UPDATED)

Another treatment in the country's arsenal against the virus.

by Ikmal Rozlan
March 4, 2022
pfizer paxlovid covid-19 treatment pills

Pfizer's Paxlovid antiviral pills. [Photo: Pfizer]

218
SHARES
Share on FacebookShare on Twitter

UPDATE (5 MAR / 4:20 PM): Health Minister Khairy Jamaluddin has confirmed that Malaysia will receive 110,000 patient-courses of Paxlovid in two weeks. As for the treatments from Merck and AstraZeneca, the government also has plans to buy them but it has not been finalised yet.

ORIGINAL STORY (4 MAR / 1:25 PM):

Director-General of Health Dr Noor Hisham Abdullah has announced that the Drug Control Authority (DCA) has given conditional approval for the Paxlovid COVID-19 treatment drug made by pharmaceutical firm Pfizer. The product registration holder is Pfizer Malaysia and it is only approved for use on adults over 18 with a high risk of contracting severe symptoms from the virus.

ADVERTISEMENT

Paxlovid is a combination treatment using nirmatrelvir and ritonavir, taken orally and has been shown in clinical trials to be highly effective at preventing hospitalisation and death. Dr Noor Hisham reminded the public that the treatment is not a replacement for the vaccine and people should still do their best to follow SOPs.

Paxlovid’s packaging for the US market. [Image: Pfizer / FDA – pdf.]

The Ministry of Health (MoH) had already announced back in December that it was planning to procure the drug for use here, but did not reveal how many courses will be purchased. Aside from Paxlovid, Malaysia also plans to buy treatment drugs from AstraZeneca and Merck, although the latter will only submit its pill for approval sometime this year. Another COVID-19 treatment called Ronapreve is also already in use in Sarawak.

The Pfizer treatment has already been approved in the US, UK, the European Union, Israel, South Korea, Canada, China, and Singapore. The price of the drugs have not been revealed, but for reference, it cost the US government US$530 (~RM2200) for each five-day course which is cheaper than Merck’s molnupiravir at US$700 (~RM2900) for a five-day course.

(Source: Director-General of Health.)

What’s your Reaction?
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0

Follow us on Instagram, Facebook, Twitter or Telegram for more updates and breaking news. 

Filed Under COVID-19Drugpaxlovidpfizertreatment
Updated 4:24 pm, Sat, 5 March 22
Back to top
Share87Tweet55SendShare

RELATED ARTICLES

selangor covid-19 face mask
Coronavirus

Selangor Is The Latest State To Consider Mandatory Face Masks

by Ikmal Rozlan
January 13, 2023
face masks
Coronavirus

Melaka Considers Making Masks Mandatory Again

by Ikmal Rozlan
January 4, 2023
[Image: Mufid Majnun / Unsplash.]
Coronavirus

Sabah Mulls Over Mandatory COVID-19 Testing For Visitors From China

by Ikmal Rozlan
January 3, 2023
vaccine ppv covid-19 vaccine booster
Coronavirus

COVID-19 Walk-In Booster Shots To Be Available For The Elderly, High-Risk Individuals

by Ikmal Rozlan
December 30, 2022

ADVERTISEMENT

LOWYAT.TV

No Result
View All Result

TRENDING TODAY

  1. 1
    Mobile Phones

    Samsung Galaxy S23 Ultra Goes Official: Price In Malaysia Starts At RM5,699

  2. 2
    Wearables

    Samsung Galaxy Watch Blood Pressure And ECG Feature Now Available In Malaysia

  3. 3
    Transportation

    Believe It: We Just Paid For A MRT Ride In Kuala Lumpur Using An Apple Watch

  4. 4
    Coronavirus

    Malaysia Gives Conditional Approval For Pfizer’s Paxlovid COVID-19 Drug (UPDATED)

  5. 5
    Banking

    Maybank Launches Own Kill Switch For Maybank2u

Consumer Tech News & Reviews Malaysia

NETWORK

  • Hype
  • Murai
  • Lipstiq
  • Diva
  • Varnam
  • Moviedash
  • Autofreaks

ABOUT

  • Advertise
  • Careers
  • Privacy Statement
  • Contact Us
  • Editorial Policy
  • Terms & Conditions

©2023 VIJANDREN RAMADASS. ALL RIGHTS RESERVED.

No Result
View All Result
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Hardware
      • Compu-zone
      • Viewnet
      • Thundermatch
      • Sri Computers
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables

©2023 LOWYAT, LLC. ALL RIGHTS RESERVED.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies to improve your experience. Learn More.